Edouard J. Trabulsi

Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer

Elizabeth R. Plimack, Roland L. Dunbrack, Timothy Brennan et al. · European Urology · 2015 · 526 citations · Full text

Genome Instability, Urology, Neoadjuvant Cisplatin-based Chemotherapy +9

Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Is Safe, Effective, and Efficient Neoadjuvant Treatment for Muscle-Invasive Bladder Cancer: Results of a Multicenter Phase II Study With Molecular Correlates of Response and Toxicity

Elizabeth R. Plimack, Jean Hoffman‐Censits, Rosalia Viterbo et al. · Journal of Clinical Oncology · 2014 · 278 citations · Full text

Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019

Veda N. Giri, Karen E. Knudsen, William Kevin Kelly et al. · Journal of Clinical Oncology · 2020 · 273 citations · Full text

Targeting Metastatic Prostate Cancer With Radiolabeled Monoclonal Antibody J591 to the Extracellular Domain of Prostate Specific Membrane Antigen

Neil H. Bander, Edouard J. Trabulsi, Lale Kostakoğlu et al. · The Journal of Urology · 2003 · 259 citations

Genomic Classifier Identifies Men With Adverse Pathology After Radical Prostatectomy Who Benefit From Adjuvant Radiation Therapy

Robert B. Den, Kasra Yousefi, Edouard J. Trabulsi et al. · Journal of Clinical Oncology · 2015 · 210 citations · Full text